Search - tctmd.com

Displaying 601 - 620 of 808

Sort: Relevancy | Date

Presentation TCT 2012

From PEPPER to DELUX Registry: BTHC-Based PCB Coating (BIOTRONIK)

Presenter: Christoph Naber

October 25, 2012

Presentation TCT 2012

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Presenter: Antonio Colombo

October 25, 2012

Presentation TCT 2012

FDA's Perspective

Presenter: Ashwani Sastry

October 25, 2012

Presentation TCT 2012

FDA Perspectives(2)

Presenter: Andrew Farb

October 25, 2012

Presentation TCT 2012

EXAMINATION 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Manel Sabate

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

Presentation TCT 2012

DES-Type Results with a DCB Plus BMS in Native Coronary Arteries? INDICOR Results (B. Braun Medical)

Presenter: Upendra Kaul

October 25, 2012

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

Presentation TCT 2012

Coronary ISR: An Accepted Clinical Indication in the DES World?

Presenter: Huay Cheem Tan

October 25, 2012

Presentation TCT 2012

Are Bioabsorbable Vascular Scaffolds Really a Breakthrough?

Presenter: Ron Waksman

October 25, 2012

Presentation TCT 2012

A Clinician's Perspectives

Presenter: David Kandzari

October 25, 2012

Presentation TCT 2012

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

Presenter: Pasi Karjalainen

October 24, 2012

Presentation TCT 2012

If You Want the Truth, Randomize!

Presenter: Robert Harrington

October 24, 2012

Presentation TCT 2012

Bioabsorbable Stent Components and Stents

Presenter: Shigeru Saito

October 24, 2012

Presentation TCT 2012

Registries Get at Reality: ASCERT and Others!

Presenter: William Weintraub

October 24, 2012

Presentation TCT 2012

Yukon (Translumina) Program Update

Presenter: Julinda Mehilli

October 23, 2012

Presentation TCT 2012

VESTAsync (MIV Therapeutics) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

Presenter: Sunao Nakamura

October 23, 2012

Presentation TCT 2012

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

Presenter: Harald Rittger

October 23, 2012

Advertisement

From PEPPER to DELUX Registry: BTHC-Based PCB Coating (BIOTRONIK)

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

FDA's Perspective

FDA Perspectives(2)

EXAMINATION 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction

Evaluation and Treatment of In-Stent Restenosis

DES-Type Results with a DCB Plus BMS in Native Coronary Arteries? INDICOR Results (B. Braun Medical)

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Coronary ISR: An Accepted Clinical Indication in the DES World?

Are Bioabsorbable Vascular Scaffolds Really a Breakthrough?

A Clinician's Perspectives

Late Bare Metal Stent Thrombosis in the Light of OCT: Management Options?

If You Want the Truth, Randomize!

Bioabsorbable Stent Components and Stents

Registries Get at Reality: ASCERT and Others!

Yukon (Translumina) Program Update

VESTAsync (MIV Therapeutics) Program Update

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with...

TCT-69. PEPCAD-DES: A Randomized, Multicenter, Single Blinded Trial Comparing Paclitaxel Coated Balloon Angioplasty with Plain Balloon Angioplasty in Drug-eluting-stent...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content